Angelo Pugliese

1.5k citations

23 papers · 1.1k indexed · h-index 16

Impact in

Biochemistry top 5%
- Phytochemicals and Antioxidant Activities
Pharmacology top 5%
- Ginger and Zingiberaceae research

Papers in

Geriatrics and Gerontology 3
- Sirtuins and Resveratrol in Medicine 3
Pharmacology 5
- Pharmacogenetics and Drug Metabolism 3

Co-authors: Zigang Dong Ann M. Bode Yong‐Yeon Cho Marc C. Nicklaus Markus Sitzmann Chul‐Ho Jeong Chenzhong Liao Jung‐Hyun Shim
Journals: Cancer Research (7 papers)Journal of Biological Chemistry (3 papers)Future Medicinal Chemistry (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Journal of Chemical Information and Modeling (1 paper)
Partner nations: United States United Kingdom South Korea

In The Last Decade

Angelo Pugliese

23 papers receiving 1.1k citations

Peers

Countries citing papers authored by Angelo Pugliese

Since Specialization

Citations

This map shows the geographic impact of Angelo Pugliese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Pugliese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Pugliese more than expected).

Fields of papers citing papers by Angelo Pugliese

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo Pugliese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Pugliese. The network helps show where Angelo Pugliese may publish in the future.

Co-authors

The 25 scholars most cited alongside Angelo Pugliese, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Angelo Pugliese Line = papers co-authored together Angelo Pugliese links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Discovery and characterization of novel TRPML1 agonists Bioorganic & Medicinal Chemistry Letters ·Xiaowen Peng, Christopher J. Holler, Андреева Елена Робертовна, K Wojcik, D.G. Dianova, Angelo Pugliese, Evelyn Herzog, Fatemeh Jafari, Mitra Adibi, Richard Gallegos, Stephanie M. McTighe, Gerhard Koenig, Raymond S Hurst, Jean‐François Blain, James C. Lanter, Duane A. Burnett	2023	3
2	Implementation of an AI-assisted fragment-generator in an open-source platform RSC Medicinal Chemistry ·Alan Bilsland, Angelo Pugliese, Justin Bower	2022	1
3	Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents Bioorganic & Medicinal Chemistry Letters ·Уляна Токарева, Daniel R. Croft, Alexander W. Schüttelkopf, Imacio Lhate, Angelo Pugliese, Rajkumari Kalpana Devi, Takashi Tsukimoto, Martin J. Drysdale, Lee Hwan sup, Andrea Gohlke, Gillian Goodwin, Christopher H. Gray, ENSAR LOKMANOĞLU, Laura McDonald, Mokdad Mezna, Andrew Pannifer, Nikki R. Paul, Laura M. Machesky, Heather J. McKinnon, Justin Bower	2019	30
4	A Central Role for Biophysics in Cancer Drug Discovery - Development of Candidate Small Molecule Inhibitors in Mutant KRas Biophysical Journal ·Andrea Gohlke, Justin Bower, Peter de Nully Brown, Rajkumari Kalpana Devi, Martin J. Drysdale, Gillian Goodwin, Christopher H. Gray, Ji Tan, علیرضا گودرزی, Heather J. McKinnon, Mokdad Mezna, Angelo Pugliese, A. Weiss	2018	2
5	Identification of a Selective G1-Phase Benzimidazolone Inhibitor by a Senescence-Targeted Virtual Screen Using Artificial Neural Networks Neoplasia ·Alan Bilsland, Angelo Pugliese, Yu Liu, Maja Domańska, Sharon Burns, Carol McCormick, Claire J. Cairney, Justin Bower, Martin J. Drysdale, Masashi Narita, Mahito Sadaie, W. Nicol Keith	2015	15
6	Fragment-based hit identification: thinking in 3D Drug Discovery Today ·Andrew Morley, Angelo Pugliese, Kristian Birchall, Justin Bower, Paul E. Brennan, Nathan Brown, Tim Chapman, Martin J. Drysdale, Ian H. Gilbert, Swen Hoelder, Allan M. Jordan, Steven V. Ley, Andy Merritt, David S. Miller, Martin E. Swarbrick, Paul G. Wyatt	2013	129
7	Computational Tools And Resources For Metabolism-Related Property Predictions. 1. Overview Of Publicly Available (Free And Commercial) Databases And Software Future Medicinal Chemistry ·Megan L. Peach, Alexey Zakharov, Ruifeng Liu, Angelo Pugliese, Gregory J. Tawa, Anders Wallqvist, Marc C. Nicklaus	2012	35
8	Computational Tools And Resources For Metabolism-Related Property Predictions. 2. Application To Prediction Of Half-Life Time In Human Liver Microsomes Future Medicinal Chemistry ·Alexey Zakharov, Megan L. Peach, Markus Sitzmann, Igor Filippov, Alshyma Alfatih Mohamed Abdallah, Layton H. Smith, Angelo Pugliese, Marc C. Nicklaus	2012	29
9	Software and Resources for Computational Medicinal Chemistry Future Medicinal Chemistry ·Chenzhong Liao, Markus Sitzmann, Angelo Pugliese, Marc C. Nicklaus	2011	117
10	Abstract 2884: Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A4 hydrolase Cancer Research ·Ming-yang Ba, Naomi Oi, Chul‐Ho Jeong, Janos Nadas, Angelo Pugliese, Ann M. Bode, Zigang Dong	2011	1
11	Resveratrol, a Red Wine Polyphenol, Suppresses Pancreatic Cancer by Inhibiting Leukotriene A4 Hydrolase Cancer Research ·Naomi Oi, Chul‐Ho Jeong, Janos Nadas, Yong‐Yeon Cho, Angelo Pugliese, Ann M. Bode, Zigang Dong	2010	79
12	Eriodictyol Inhibits RSK2-ATF1 Signaling and Suppresses EGF-induced Neoplastic Cell Transformation Journal of Biological Chemistry ·Kangdong Liu, Yong‐Yeon Cho, Ke Yao, Janos Nadas, Dong Joon Kim, Eun Jin Cho, Mee‐Hyun Lee, Angelo Pugliese, Jishuai Zhang, Ann M. Bode, Ziming Dong, Zigang Dong, (unknown), (unknown)	2010	52
13	Role of NEK6 in Tumor Promoter-induced Transformation in JB6 C141 Mouse Skin Epidermal Cells Journal of Biological Chemistry ·Young Jin Jeon, Kun Yeong Lee, Yong‐Yeon Cho, Angelo Pugliese, R Oktafiani, Chul‐Ho Jeong, Ann M. Bode, Zigang Dong	2010	41
14	Anti-cancer gallotannin penta-O-galloyl-beta-d-glucose is a nanomolar inhibitor of select mammalian DNA polymerases Biochemical Pharmacology ·Yoshiyuki Mizushina, Jinhui Zhang, Angelo Pugliese, Sung‐Hoon Kim, Junxuan Lü	2010	20
15	[6]-Gingerol Suppresses Colon Cancer Growth by Targeting Leukotriene A4 Hydrolase Cancer Research ·Chul‐Ho Jeong, Ann M. Bode, Angelo Pugliese, Yong‐Yeon Cho, Hong-Gyum Kim, Jung‐Hyun Shim, Young-Jin Jeon, Honglin Li, Hualiang Jiang, Zigang Dong	2009	149
16	A Regulatory Mechanism for RSK2 NH2-Terminal Kinase Activity Cancer Research ·Yong‐Yeon Cho, Ke Yao, Angelo Pugliese, Margarita Malakhova, Ann M. Bode, Zigang Dong	2009	58
17	Cyclin-Dependent Kinase-3–Mediated c-Jun Phosphorylation at Ser63 and Ser73 Enhances Cell Transformation Cancer Research ·Yong‐Yeon Cho, Faqing Tang, Ke Yao, Chengrong Lu, Feng Zhu, Duo Zheng, Angelo Pugliese, Ann M. Bode, Zigang Dong	2008	54
18	The resveratrol analogue 3,5,3′,4′,5′‐pentahydroxy‐trans‐stilbene inhibits cell transformation via MEK International Journal of Cancer ·Ki Won Lee, Nam Joo Kang, Evgeny A. Rogozin, Sang‐Muk Oh, Yong Seok Heo, Angelo Pugliese, Ann M. Bode, Hyong Joo Lee, Zigang Dong	2008	20
19	(-)-Epigallocatechin Gallate Regulates CD3-mediated T Cell Receptor Signaling in Leukemia through the Inhibition of ZAP-70 Kinase Journal of Biological Chemistry ·Jung‐Hyun Shim, Hong Seok Choi, Angelo Pugliese, Sung‐Young Lee, Jung‐Il Chae, Bu Young Choi, Ann M. Bode, Zigang Dong	2008	86
20	Raf and MEK Protein Kinases Are Direct Molecular Targets for the Chemopreventive Effect of Quercetin, a Major Flavonol in Red Wine Cancer Research ·Ki Won Lee, Nam Joo Kang, Yong‐Seok Heo, Evgeny A. Rogozin, Angelo Pugliese, Mun Kyung Hwang, G. Tim Bowden, Ann M. Bode, Hyong Joo Lee, Zigang Dong	2008	159

About Angelo Pugliese

Angelo Pugliese is a scholar working on Geriatrics and Gerontology, Pharmacology, Applied Microbiology and Biotechnology, Computational Theory and Mathematics and Information Systems and Management, having authored 23 papers that have together received 1.1k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (6 papers), Machine Learning in Materials Science (3 papers), Sirtuins and Resveratrol in Medicine (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Melanoma and MAPK Pathways (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Metabolomics and Mass Spectrometry Studies (2 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). The work is most often cited by research in Biochemistry (124 citations), Pharmacology (136 citations), Geriatrics and Gerontology (57 citations), Computational Theory and Mathematics (211 citations) and Applied Microbiology and Biotechnology (21 citations). Angelo Pugliese has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include Zigang Dong, Ann M. Bode, Yong‐Yeon Cho, Marc C. Nicklaus, Markus Sitzmann, Chul‐Ho Jeong, Chenzhong Liao, Jung‐Hyun Shim, Ke Yao and Nam Joo Kang. Their work appears in journals such as Cancer Research, Journal of Biological Chemistry, Future Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Journal of Chemical Information and Modeling.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact